[Immunostimulant therapy of kidney diseases].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000686:Amyloidosis / Q000188:drug therapy; D000818:Animals; D001327:Autoimmune Diseases / Q000188:drug therapy; D001402:B-Lymphocytes / Q000276:immunology; D002908:Chronic Disease; D005921:Glomerulonephritis / Q000188:drug therapy; D006801:Humans; D007105:Immune Complex Diseases / Q000188:drug therapy; D007372:Interferons / Q000627:therapeutic use; D007674:Kidney Diseases / Q000188:drug therapy* / Q000276:immunology; D007978:Levamisole / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D051379:Mice; D051381:Rats; D013601:T-Lymphocytes / Q000276:immunology; D013947:Thymosin / Q000627:therapeutic use; D014165:Transfer Factor / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D014165:Transfer Factor; D007978:Levamisole; D013947:Thymosin; D007372:Interferons
Imunostimulirashta terapiia pri bubrechni zaboliavaniia.